ASTRAZENECA PLC (AZN) Business News Aug. 13, 2026, 13:28 UTC Clinical trial NCT06526793: primary completion date: 2027-11-24 → 2028-04-21. Full text
Register to leave comments News bot Aug. 13, 2026, 1:32 p.m. 📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical